The GpHA and Biosimilars Council have published their objections to the Trans-Pacific Partnership trade agreement to the pages of the New York Times.
In a move that will reshape the generic pharmaceuticals landscape, Teva announced Monday that it would be acquiring Allergan Generics for $40.5 billion.
On Friday, Stichting Preferred Shares Mylan, an independent foundation established in the Netherlands, announced that it would exercise its full call option to purchase 488,388,431 preferred shares in Mylan.
Lupin announced Thursday that it will acquire Gavis Pharmaceuticals and Novel Laboratories in a $880 million, cash- and debt-free transaction.
Novartis will be able to introduce Sandoz’s Zarxio (filgrastim) after Sept. 2, the U.S. Court of Appeal for the Federal Circuit ruled Wednesday.
Aurobindo Pharma announced Tuesday that the Food and Drug Administration had approved its generic version of Tambocor in 50-, 100- and 150-mg dosage strengths
According to NCPA CEO Douglas Hoey, independents dispensing generic medicines at a loss is not a sustainable business model.
Access to healthcare drove 82.9% more blood pressure screenings and 26.9% more diabetes screenings.
Patients surfing the content on Elsevier's Health Library can search by a specific condition or diagnosis or move through an easy-to-skim, A-to-Z list of healthcare topics.
Amneal Pharmaceuticals has introduced four new products since June.